tiprankstipranks
pc:adcen

Adcendo

Adcendo is a biotechnology company specializing in the development of first-in-class antibody-drug conjugates (ADCs) aimed at treating cancers with high unmet medical needs. The company is advancing multiple ADC programs into clinical trials to establish clinical proof of concept, focusing on innovative treatments that target specific cancer pathways.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$135M
Total Amount Raised$135M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$135M
Latest Funding Amount$135M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Aug 14, 2025
Series B
$135.00M

Investors

Investor Name
Funding Round

Related News and Analysis